Next Article 
Molecular and Cellular Biology, May 2001, p. 2969-2980, Vol. 21, No. 9
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.9.2969-2980.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Sequences Flanking Hypersensitive Sites of the
-Globin Locus Control Region Are Required for Synergistic
Enhancement
Joseph M.
Molete,1
Hanna
Petrykowska,1
Eric E.
Bouhassira,3
Yong-Qing
Feng,3
Webb
Miller,2 and
Ross C.
Hardison1,*
Department of Biochemistry and Molecular
Biology1 and Department of Computer
Science and Engineering,2 The Pennsylvania State
University, University Park, Pennsylvania, and Department of
Medicine, Division of Hematology, Albert Einstein College of Medicine,
Bronx, New York3
Received 19 October 2000/Returned for modification 19 December
2000/Accepted 9 February 2001
 |
ABSTRACT |
The major distal regulatory sequence for the
-globin gene locus,
the locus control region (LCR), is composed of multiple hypersensitive
sites (HSs). Different models for LCR function postulate that the HSs
act either independently or synergistically. To test these
possibilities, we have constructed a series of expression cassettes in
which the gene encoding the enhanced green fluorescent protein
(EGFP) is under the control of DNA fragments containing single and multiple HSs of the LCR. LCR DNA fragments containing only
the minimal region needed for position-independent expression (HS
cores) or containing cores plus flanking sequences (HS units) were
compared to ascertain whether conserved sequences between the HS cores
contributed to enhancement. Expression of these constructs was measured
after targeted integration into three defined loci in murine
erythroleukemia cells using recombinase-mediated cassette exchange. At
all three marked loci, synergistic enhancement of expression was
observed in cassettes containing a combination of HS2, HS3, and HS4
units. In contrast, HS2, HS3, and HS4 cores (without flanking
sequences) give an activity equivalent to the sum of the activities of
the individual HS cores. These data suggest a model in which an HS core
plus flanking regions, bound by specific proteins, forms a structure
needed for interaction with other HS units to confer strong enhancement
by the LCR. The three targeted integration sites differ substantially
in their permissivity for expression, but even the largest LCR
construct tested could not overcome these position effects to confer
equal expression at all three sites.
 |
INTRODUCTION |
Genes in the
-globin gene complex
(HBBC, containing HBE1, HBG2, HBG1, HBD, and
HBB), together with those in the
-globin gene complex
(HBZ2, HBA2, and HBA1) encode the developmentally regulated, erythroid-specific family of hemoglobins in vertebrates. Transcription of the mammalian HBBC is regulated both by
proximal elements, such as promoters, and by a distal regulatory
element known as the locus control region (LCR). The LCR is marked by several hypersensitive sites (HSs) in erythroid chromatin (18, 45) and is required for high-level expression of genes within the HBBC in erythroid cells (reviewed in references 6
and 19). Transfection and transgenic mouse studies show that the
LCR confers this high-level expression at many, but perhaps not all,
ectopic sites of integration (1, 21, 31). Gain-of-function
experiments examining multiple integrated copies of LCR constructs
revealed expression that is copy number dependent and independent of
the site of integration (e.g., see references 43 and 44),
suggesting that the LCR contains a dominant chromatin-opening activity.
However, deletion of HS1 to HS6 from the LCR of mouse Hbbc
(3, 12), as well as deletion of HS2 to HS5 from the LCR of
human HBBC on chromosome 11 (37), leaves the
globin genes in an open chromatin domain, albeit expressed at very low
to undetectable levels. Thus, the LCR is clearly required for
enhancement but it is not necessary for chromatin domain opening at the
normal chromosomal position.
The core of each HS can be defined as the minimal DNA fragment capable
of conferring high-level expression on a linked globin gene in
transgenic mice; these cores tend to be 200- to 400-bp fragments (e.g.,
see references 35 and 44). Numerous studies have examined
the roles of individual HSs in various expression assays (reviewed in
references 20 and 22). HS2 contains a strong enhancer that
functions both in transient assays and in stably transfected cells. HS3
can also enhance expression of globin genes, with its major function
seen after integration. HS4 does not enhance by itself but can
contribute increased expression in combination with other HSs
(11). HS1 appears to be dispensable, since a naturally
occurring deletion encompassing it does not affect
-globin gene
expression (28). HS5 is absent from rabbits (7), and no phenotype was observed when HS5 and HS6 were
deleted from mouse Hbbc (2). Thus, the bulk of
the known function for the LCR maps to the region encompassing HS2,
HS3, and HS4.
Despite the substantial effects of HS2 and HS3 in gain-of-function
assays, only a small decrease in globin gene expression was observed
when HS2 or HS3 (in each case including some flanking DNA) was deleted
from the endogenous mouse Hbbc locus (16, 23) or from a YAC with 150 kb encompassing the HBBC in
transgenic mice (34). This could be explained by one or
more of the remaining HSs substituting for the function of the deleted
HS. This, in turn, implies that the remaining HSs function
independently of the deleted HS and enhance at a level almost
comparable to that of the intact LCR. A distinctly different phenotype
was seen when only the HS cores were deleted from the HBBC
carried in large YACs in transgenic mice. Deletion of the cores of HS2,
HS3, or HS4 (with no flanking DNA) caused a dramatic reduction in the expression of all of the
-like globin genes (8, 9, 32). In these constructs, the remaining HSs of the LCR were unable to form a
strong enhancer (despite the fact that the DNase hypersensitivity was
retained in several cases), implying that the various HSs have to act
together, synergistically, in an LCR holocomplex to enhance globin gene
expression (8). Analysis of an extensive set of single-HS
deletions in transgenic mice containing the HBBC shows that
deletion of any HS makes the transgenic locus susceptible to two
different kinds of chromosomal position effects (31), also
arguing that the components of the LCR form an interactive holocomplex
(47).
Direct evidence for synergistic interactions has been obtained in a few
studies. Combinations of three HSs were needed for expression of
HBB beyond that obtained with a single HS in transfected murine erythroleukemia (MEL) cells (11). Synergism between
HS2 and HS3 was observed for enhanced expression of a rabbit
HBE-luciferase reporter gene in stably transfected K562
cells (25, 26). Synergism among HS2, HS3, and HS4 was
inferred for long-range activation of an HBG1 reporter gene
in stably transfected K562 cells (5). In each of these
cases, the LCR constructs contained both the HS cores and flanking DNA,
and Jackson et al. (25) showed that the flanking DNA was
needed, since only additive increases were observed when combinations
of HS cores were used.
Further evidence for the importance of sequences between (or flanking)
the HS cores comes from analysis of interspecies sequence alignments,
which reveal many conserved blocks both within and between HS cores
(22). In a direct test, larger DNA fragments containing
single HSs plus flanking DNA showed significantly stronger enhancement
of an HBE-luciferase reporter after stable integration into
K562 cells (26) than did the cores alone. Indeed, earlier studies had mapped additional functions outside the core of HS2 (10, 29, 44). We refer to a DNA fragment containing the HS
core plus flanking DNA as an "HS unit" (25).
A complication in interpreting the results of the above-described
studies with transgenic mice and stably transfected cells is the effect
of the integration site on expression. For instance, a set of clones
containing the same DNA construct but with a different number of copies
at different integration sites shows a range of expression levels, even
after correction for copy number (e.g., see references 25 and
26). Although significant differences were observed between
constructs, one cannot rule out some contribution from position
effects, even when examining pools of clones. Moreover, lines of
transgenic mice carrying one or two copies of 150-kb YACs or large BACs
encompassing the HBBC (with an intact LCR) are subject to
position effects (1, 36). Thus, interpretation of studies
comparing different LCR mutations within the context of a large region
containing the HBBC in transgenic mice is still complicated
by the influence of particular integration sites.
Therefore, techniques have been developed that target integration of a
single copy of a test construct to specified chromosomal locations
(4, 33, 40, 41). These techniques allow expression of a
series of test constructs to be compared at the same site. The
integrated constructs are subject to exactly the same effects of
flanking DNA, and complications arising from site-to-site variation in
position effects are eliminated. At the same time, only single copies
of the integrant are obtained, thus removing copy number as a variable
in the experiment. In this study, we used the technique of
recombinase-mediated cassette exchange, or RMCE (4, 15), to compare the effects of LCR HS cores and HS units, singly and in
combination, on expression of an HBB-enhanced green
fluorescent protein (EGFP) reporter integrated into MEL cells. The
constructs were examined at three different chromosomal locations, RL4,
RL5, and RL6, in both orientations (14). We found that
HS2, HS3, and HS4 units (but not cores) can interact to produce a level of enhancement beyond the sum of the effects observed with the individual HS cores. Thus, DNA fragments containing the cores plus
flanking DNA are needed for synergism among the HSs of the LCR. Despite
this synergistic activation, even large DNA fragments containing all of
the major functional sequences in the LCR cannot overcome the position
and orientation effects seen at these integration sites.
 |
MATERIALS AND METHODS |
Plasmids for RMCE.
The expression plasmid L1-
-EGFP-1L,
into which all of the LCR fragments were inserted, was described by
Feng et al. (15). Briefly, the promoter of the human
-globin gene (HBB), on a DNA fragment extending from
374 to +44 relative to the cap site, replaced the cytomegalovirus
(CMV) promoter in plasmid pEGFP-N1 (Clontech, Palo Alto, Calif.), and
inverted Lox sites L1 (Lox1) and 1L (1Lox) were placed at the 5' and 3'
ends of the cassettes, respectively (15). An
oligonucleotide containing restriction endonuclease cleavage sites
designed for insertion of LCR DNA fragments (MCS in Fig.
1) was added 5' to the HBB
promoter, and a series of DNA fragments from the
-globin LCR were
inserted (Fig. 1). The restriction endonucleases used and the positions of the DNA fragments containing HSs are listed in Table
1. Plasmid L1-HS432_pTR-1L contains a
9.2-kb LCR segment encompassing HS2, HS3, and HS4 obtained from pTR68
(38). Plasmid L1-HS432_mLAR-1L contains linked DNA
fragments containing units of HS2, HS3, and HS4 (a total of 3.5 kb)
excised from plasmid mLAR (17). Plasmid L1-HS432_cores-1L
contains a linked set of cores for HS2, HS3, and HS4 (a total of 1.0 kb, with HS4 in the opposite orientation to HS3 and HS2) as described
by Sadelain et al. (39). Cre expression plasmid
pBS185(CMV-CRE) was obtained from Clontech.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 1.
Maps of the human LCR fragments and EGFP
expression cassettes used in this study. The top line shows the
HBB complex, and the next line shows the positions of the
HS2, HS3, and HS4 cores, using the coordinates in GenBank locus HUMHBB
(accession number U01317). The next eight lines show the segments of
the LCR inserted into the expression cassette, which is diagrammed on
the last line. It contains the HBB promoter linked to an
EGFP reporter gene, preceded by multiple cloning sites (MCS)
and flanked by Lox1 and 1Lox. The names of the cassettes are on the
left, and the sizes of the LCR inserts are on the right.
|
|
Transfection, selection, and screening.
MEL cells marked by
integration of a plasmid containing L1-CMV-HYTK-1L at one of three
different chromosomal locations, RL4, RL5, or RL6 (14),
were grown in Dulbecco's modified Eagle medium (DMEM) containing 10%
bovine calf serum, 2% penicillin and amphotericin B (Fungizone), and
hygromycin at 1 mg/ml for at least 3 days prior to electroporation.
RMCE was performed as described by Bouhassira et al. (4),
using 200 µg of the test plasmid, 50 µg of the CRE expression
plasmid, and electroporation at 450 V and 500 µF. Cells in which the
HYTK cassette is replaced with the test construct are resistant to
gancyclovir. Thus, transfected cells were plated in soft agar
containing DMEM, 10% bovine calf serum, 2% penicillin and
amphotericin B, and 12 µM gancyclovir. Individual colonies were
picked after 2 weeks and expanded in liquid culture containing gancyclovir.
Colonies containing a single integrant at RL4, RL5, and RL6 were
identified by analysis of genomic DNA. Southern blots containing 20 µg of genomic DNA were digested with BglII and hybridized
to a DNA probe from the gene for EGFP. In cases where orientation could
not be identified from a single digest, a double digestion with
BglII and HindIII was performed and a DNA
fragment containing HS4 was used as a probe.
EGFP measurements.
To measure the level of EGFP, a sample of
each cell culture containing 106 cells was resuspended in
phosphate-buffered saline and 2 µM propidium iodide and analyzed on a
flow cytometer (Beckman-Coulter XL-MCL). Rainbow calibration particles
(RCP-30-5; Spherotech Inc.) coated with defined amounts of fluorescein
were analyzed under the same conditions as the cells and used to
construct a standard curve. This standard curve was used to convert the
median of the distribution of EGFP levels to relative molecules of
equivalent fluorescein (MEFL). The means of these median values for
multiple clones (in most cases, three clones) and the standard
deviations were calculated for both orientations of each cassette. The
significance of differences in the means was calculated using Students
t test. Cells were assayed for EGFP within 6 weeks after isolation.
The amount of EGFP fluorescence expected for additive effects of HS
cores was calculated by first subtracting the fluorescence level for
the
-EGFP cassette from that for each HS core cassette. These
adjusted levels were then added to the fluorescence level for the
-EGFP cassette, effectively adding in the signal from the
HBB promoter only once. Fluorescence substantially above
this level was interpreted as a synergistic effect.
Induction.
To test the inducibility of various
LCR-containing cassettes, 5 × 104 cells from selected
clones were incubated in DMEM containing 4 mM
N,N'-hexamethylene-bis-acetamide (HMBA) at 37°C
for 6 days. Increased production of hemoglobin was evident by the red
color of the induced cell pellet. The EGFP levels in the induced cells and uninduced cells were compared by flow cytometry.
 |
RESULTS |
Synergism among HS units after integration at the
permissive RL5 locus.
The expression cassette used in these
studies contained the gene (EGFP) encoding EGFP and the
human HBB promoter flanked by Lox sites in the inverted
orientation (Lox1 and 1Lox, Fig. 1). Various fragments of the
-globin LCR were ligated into the multiple cloning sites upstream of
the promoter (Fig. 1). Each plasmid was electroporated into marked MEL
cells along with a Cre expression plasmid so that the entire cassette
replaced a HYTK cassette at the desired integration site
(15), rendering the targeted cells resistant to
gancyclovir. Individual clones were then selected and screened for
single-copy integrants at the desired sites. Levels of EGFP were
measured by flow cytometry.
Figure 2 shows the results of genomic
Southern blot assays of clones selected after cassette exchange at RL5
in MEL cells. After integration of the reporter construct
-EGFP
(i.e., no LCR), digestion of the genomic DNA with BglII,
followed by hybridization with an EGFP probe, yielded a
4.2-kb fragment in orientation A and a 5.2-kb fragment in orientation B
(Fig. 2A). The sizes expected after replacement with the LCR-containing
cassettes were calculated by adding the size of the LCR fragments to
the size of the BglII fragments seen for
-EGFP. For all
constructs, clones were found for which the sizes of the observed bands
closely matched the expected sizes for both orientations. At least
three individual clones for each orientation were obtained from this
screen. Given the large size of the BglII fragments
containing the HS432_pTR cassette, a single enzyme digest could not
distinguish the orientation. By utilizing a double digest with
HindIII and BglII and hybridizing the blot
with an HS4 probe (Fig. 2B), fragments of 6.0 or 3.4 kb were obtained,
which are distinctive for orientations A and B, respectively. Common
bands of 1.9 and 2.4 kb result from a cross hybridization between
Alu repeat sequences in the probe and those in the fragments
containing HS2 and HS3.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 2.
Southern blot hybridization data showing integration of
expression cassettes at RL5 of MEL cells by RMCE. (A) Analysis with
BglII (Bg). The maps at the top show the sizes of the
inserts obtained from integration of the -EGFP (no LCR) cassette
into RL5 MEL cells in each orientation and the BglII
fragments detected with an EGFP probe. Below the maps are
blot hybridization data for genomic DNA purified from
gancyclovir-resistant clones, digested with BglII, and
hybridized with labeled DNA containing the EGFP coding
sequence. Representative clones are showed for each construct in each
orientation. (B) Analysis with BglII and
HindIII (H). To distinguish the two orientations of the
HS432_pTR cassette at RL5, genomic DNA was digested with
BglII and HindIII and hybridized to an HS4
probe. Orientation A was identified by the presence of a 6.0-kb band,
while orientation B has the 3.4-kb band. Positions of the hybridization
probe and the Alu repeats are indicated below the maps.
|
|
Analysis of EGFP fluorescence by flow cytometry showed that locus RL5
is permissive for expression in both orientations. Even in the absence
of any LCR enhancers, EGFP was produced in all of the cells (Fig.
3,
-EGFP construct). Addition of HS3
or HS2 caused an increase in the median level of fluorescence,
indicating a higher level of expression of the EGFP gene
(Fig. 3), whereas HS4 had no effect. All of the cells in the population
increased their EGFP signal when an enhancer was added; the fraction of cells expressing EGFP did not change. The mean fluorescence
for at least three individual clones is plotted in Fig.
4 for comparisons among the cassettes.
HS2 has a stronger effect than HS3 (4.4- to 6.5-fold enhancement for
orientations B and A of the HS2_unit cassette, compared to 2.6- to
4.0-fold for the HS3_unit cassette). No significant difference was seen
between the HS cores and HS units (P > 0.9 by
Student's t test) for both HS3_unit versus core and
HS2_unit versus core. No difference in EGFP fluorescence was observed
between the two orientations with the individual HSs; however,
orientation A with a combination of HSs enhanced 1.5- to 2.0-fold more
than orientation B. This orientation difference is significant for
HS432_cores, HS432_mLAR, and HS432_pTR cassettes (P < 0.001).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 3.
Flow cytometric analysis of clones containing -EGFP
cassettes (with and without the LCR) in MEL cells at locus RL5. Ten
thousand cells were counted, and the results were plotted as the number
of cells (y axis) versus the intensity of EGFP fluorescence
(x axis). The MEL cells are RL5 cells before transfection;
this shows the background fluorescence in the absence of
EGFP expression. A and B are the orientations in which the
cassette is integrated into the RL5 locus. The median of the EGFP peak
is given in each graph.
|
|

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 4.
Expression of EGFP in MEL cell clones
containing -EGFP (with and without the LCR) cassettes at RL5. EGFP
levels were measured in multiple clones containing a single integrant
of the indicated constructs in each orientation (A or B). EGFP levels
are reported as MEFL. The median values for at least three clones were
averaged and plotted as bars with standard deviations. The EGFP levels
expected for addition of the effects of individual HS4, HS3, and HS2
cores are indicated at the top. The ratio of the mean MEFL for each
cassette to the mean MEFL for the -EGFP cassette is listed as the
fold enhancement on the right. pr, promoter; MCS, multiple cloning
sites.
|
|
Combinations of HSs gave EGFP fluorescence levels higher than those
seen for the individual HSs. Linking of the HS4, HS3, and HS2 cores
produced a fluorescence equivalent to that expected for addition of the
effects of the individual HS cores (Fig. 4). In particular, the linked
cores in orientation A produced EGFP fluorescence only slightly above
that expected for addition of the effects of the cores, and in
orientation B, the effect was slightly below that expected for an
additive effect. In contrast, combinations of the units for HS4, HS3,
and HS2 enhanced at markedly greater levels (up to 29.0-fold, compared
to 12-fold for the combination of cores). This level of fluorescence is
substantially greater than that expected for addition of the cores
(Fig. 4). This difference is statistically significant for both the
HS432_pTR cassette versus the HS432_cores cassette and the HS432_mLAR
cassette versus the HS432_cores cassette (P < 0.001
for each comparison). Hence, HSs of the LCR can interact to obtain
greater-than-additive (i.e., synergistic) increases in enhancement.
This effect requires DNA fragments containing cores plus flanking DNA
(HS units), since combinations of the cores do not show synergism.
The EGFP levels measured by fluorescence assay correlate well with the
amount of EGFP RNA in the cells. The amount of
EGFP RNA in the total RNA from clones carrying cassettes at
RL5 was measured by an RNA protection assay. The fold increases in
EGFP RNA corresponded well to the fold increases in EGFP
fluorescence (data not shown). Thus, the effects of the LCR fragments
are exerted on the amount of stable RNA, which is consistent with an
effect on the level of transcription of the cassette.
Synergism among HS units in one orientation at the less permissive
locus, RL6.
The set of expression cassettes was also integrated at
locus RL6, which is not as permissive for expression as is RL5
(14). Screening of multiple clones from each transfection
allowed the selection of several clones containing each cassette in
each orientation. In the absence of LCR fragments, the
-EGFP
cassette at RL6 is not expressed at a detectable level, since the flow
profiles are virtually indistinguishable from those of the parental
cells (data not shown). Addition of LCR fragments stimulated expression
(Fig. 5), and this effect was seen in all
of the cells in the population. However, the level of expression for
each construct was considerably lower than that seen at RL5 (compare
Fig. 5 to Fig. 4). Examination of multiple clones shows that the HS2
and HS3 cores enhance significantly (P < 0.01) but HS4
does not (Fig. 5). Combining the HS4, HS3, and HS2 cores does not
increase the level of enhancement; expression of the HS432_cores
cassette is not significantly different from that of the HS2_core
cassette in either orientation. In contrast, for orientation B,
inclusion of multiple HS units in the cassette increased enhancement
significantly, from 4.0-fold for the HS432_cores cassette to 8.0-fold
for the HS432_pTR cassette (P < 0.001). The increase
in enhancement observed for the two cassettes with HS4, HS3, and HS2
units is substantially beyond that expected from addition of the
effects of the HS cores. Hence, like the situation at RL5, sequences
outside the core are needed to obtain synergistic enhancement among the
HSs.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 5.
Expression of EGFP in MEL cell clones
containing -EGFP (with or without the LCR) cassettes at RL6. EGFP
levels were measured in multiple clones containing a single integrant
of the indicated constructs in each orientation (A or B). In most
cases, the median values for at least three clones were averaged and
plotted as bars with standard deviations. pr, promote; MCS, multiple
cloning sites.
|
|
Surprisingly, inclusion of additional HSs in cassettes in orientation A
did not produce any increase beyond that of the HS2 core (Fig. 5). The
HS432_pTR construct gave only a 3.1-fold enhancement, which is
comparable to the 3.2-fold obtained with the HS2 core alone. Thus,
orientation A at RL6 has a limited capacity to respond to enhancers.
Feng et al. (14) observed no differences between orientations A and B at RL6 for expression of a construct comparable to
the HS432_mLAR cassette. This may reflect a stable alteration at this
locus, perhaps epigenetic, in the line of RL6-marked cells used in
these experiments.
Synergism among HS units in one orientation at RL4.
The set of
cassettes with different portions of the LCR was also tested at a third
locus, RL4. Clones in each orientation for all cassettes were obtained
for analysis. Feng et al. (14) have shown that orientation
A of RL4 is not permissive for expression of cassettes regulated by the
CMV promoter-enhancer or an enhancer containing HS4, HS3, and HS2 of
the LCR (comparable to the HS432_mLAR cassette). The data in Fig.
6 confirm this observation and show, in
addition, that for all of the LCR fragments tested, including the
9.2-kb fragment encompassing all of HS4, HS3, and HS2 (HS432_pTR cassette), only a low level of EGFP is produced in orientation A. In
contrast, orientation B is permissive for expression. For this
orientation, all of the cells in the population express EGFP and, hence, there is no change in the fraction of cells expressing EGFP with different LCR fragments (data not shown).

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 6.
Expression of EGFP in MEL cell clones
containing -EGFP (with or without the LCR) cassettes at RL4. EGFP
levels were measured in multiple clones containing a single integrant
of the indicated constructs in each orientation (A or B). Averages for
clones carrying the same cassettes in a given orientation are plotted
as bars with standard deviations. pr, promoter; MCS, multiple cloning
sites.
|
|
In permissive orientation B, combinations of the HS units give
substantially higher levels of enhancement (6- to 10-fold) than does
the combination of HS cores (2.1-fold). This is consistent with the
need for flanking sequences for synergistic interactions observed at
RL5 and RL6.
LCR fragments with HS4, HS3, and HS2 cannot overcome position
effects.
Figure 7 compares the
levels of expression and enhancement by cassettes containing multiple
HS sites at the three different chromosomal locations, using the most
highly expressing orientation for each site. Data for cassettes with no
LCR confirm that RL5 is the most permissive locus, RL4 (orientation B)
allows an intermediate level of expression, while RL6 is the least
active. This has been inferred by analysis of LCR-containing cassettes
(14) and is directly demonstrated in the comparison in
Fig. 7. If any of the DNA fragments from the LCR used in this study
were capable of overcoming all position effects, they should be able to
enhance to comparable levels of expression at all three loci. This was not seen. Instead, each LCR construct was able to enhance expression but the levels of expression and fold enhancement were highest at RL5,
intermediate at RL4, and lowest at RL6. Even the largest DNA fragment
tested, encompassing the most active portions of the LCR, did not
increase expression to the same level at all three integration sites.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 7.
Expression of EGFP in MEL cell clones
obtained through RMCE at three different loci. Expression levels for
cassettes containing combinations of HSs in the more highly expressing
orientation at RL4, RL5, and RL6 are presented. The mean values are
plotted as bars with standard deviations. pr, promoter; MCS, multiple
cloning sites.
|
|
Effects of induction.
The effects of different LCR fragments
on inducibility were tested with clones from each cassette in the
higher-expressing orientation at integration sites RL5 and RL4.
Cultures of clones grown in the absence or presence of the inducer HMBA
were assayed for EGFP fluorescence by flow cytometry. All of the
cassettes at RL5 induced 3.5- to 6.5-fold (Fig.
8A). At RL4, several LCR-containing cassettes induced four- to fivefold, including combinations of units,
combination of cores, and the HS3 unit alone (Fig. 8B). Induction of
the HS2 unit was only twofold, whereas the HS3 core and the cassette
with no LCR showed no response to induction. At both RL4 and RL5, the
amount of induction for cassettes containing the HS3 unit exceeded that
of those containing the HS3 core (P < 0.05 for clones
at RL5).

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 8.
Induction of EGFP expression in RMCE clones.
Expression levels for uninduced clones (U) or clones induced for 6 days
with 4 mM HMBA (I) are plotted. (A) Clones with cassettes integrated at
RL5. (B) Clones with cassettes integrated at RL4. The fold increase
upon induction is given at the right.
|
|
 |
DISCUSSION |
We have examined the expression of a series of single-copy
cassettes containing different combinations of functional elements from
the LCR at identical integration sites in MEL cells. In contrast to
experiments using randomly integrated constructs, data from this
technique are not complicated by variations in position effects or copy
numbers. We show that the components of the LCR do not work strictly
independently, but rather they can interact to produce synergistic
enhancement of the HBB promoter. These data support a model
in which the HSs of the LCR interact in a holocomplex to provide a high
level of enhancement (5, 8, 9, 24, 31, 47).
The criterion for synergism in the current study is the stimulation of
expression of an HBB-EGFP reporter to a level greater than
the sum of that stimulated by the individual HS cores. Combining the
HS4, HS3, and HS2 cores enhanced expression to a level comparable to
the sum of the enhancements by the cores. In contrast, combinations of
larger DNA fragments containing the HSs (HS units) enhanced to a
significantly higher level, indicating synergistic interactions. A
contrasting interpretation is that the HS units individually are
capable of enhancing to a greater extent than are the HS cores, thereby
producing the larger enhancements in combination. Although stronger
enhancement by HS units than HS cores has been seen in some studies
(e.g., see reference 26), this result was not obtained with single-copy integrants at the sites examined in this study; in
uninduced cells, the enhancements by cores and units are the same for
HS3 and HS2. No HS4 unit was tested in the current series of
experiments, since no difference was observed in previous experiments comparing the HS4 core and HS4 units from the rabbit LCR
(26). This leaves open the possibility that the human HS4
unit included in the HS432_miniLAR cassette has an enhancement activity
greater than that of the HS4 unit, thereby accounting for the greater activity of the combinations of units. However, this seems unlikely, given the absence of an enhancement effect for HS4 seen in several studies (20, 22). Thus, for the loci examined here, the
enhancement expected for the sum of the HS units is the same as that
expected for the sum of the HS cores in this system. The data in the
current study can be interpreted as reflecting synergistic interactions among the HSs.
The observation of synergism among larger DNA fragments of the LCR, but
not among the HS cores, shows that additional sequences outside the
cores are needed for synergistic enhancement. The ability of HS units
(i.e., cores plus flanking regions) to synergize in enhancement was
seen at all three of the loci examined. A similar result was obtained
in our earlier study of randomly integrated LCR-containing reporter
constructs, but synergism was observed between rabbit but not human LCR
HS units (25). This earlier study used a different
promoter (from the rabbit HBE gene) and a different cell
line, K562; it was limited to combinations of HS2 and HS3; and it was
subject to the complications of different position effects. Any or all
of these factors could contribute to the lack of observable synergism
between human HS units in that study. Our current approach, using RMCE
to examine expression of cassettes integrated at defined chromosomal
locations, is more sensitive and robust. These data clearly show that
the HS4, HS3, and HS2 units of the human LCR can interact
synergistically to enhance expression from the HBB promoter.
In support of this observation, recent studies utilizing LCR segments
in gene therapy vectors also show that a combination of larger LCR
fragments, comparable to our HS units, produce higher levels of
expression for a longer time than do combinations of HS cores
(30).
The DNA sequences between the HS cores contain clusters of consereved
sequence blocks, or phylogenetic footprints (22), but they
do not have enhancement activity themselves (42). Thus, they appear to be modulators of enhancement by the cores of the HSs.
Ongoing studies show that specific proteins can bind to conserved sites
between the HS cores. Proteins bound to the DNA flanking the cores may
play a structural role, placing the activator proteins bound to the HS
cores in an optimal orientation, perhaps by facilitating interactions
with other HS units.
Surprisingly, even large LCR constructs were unable to overcome
position effects at RL4, RL5, and RL6. The largest segment tested, a
9.2-kb fragment with HS4, HS3, and HS2 and all of the intercore
sequences, contains all of the major regulatory elements mapped in the
LCR. These results indicate either that important LCR functions needed
to overcome these position effects lie outside of this fragment or that
the LCR cannot overcome them. The recent demonstrations that even large
YACs and BACs containing the human HBBC (1, 36)
or mouse Hbbc (27) are sensitive to position effects argue that the LCR cannot overcome all position effects. This
raises the possibility that strategies based on random integration are
not effective long-term approaches to genetic therapy of disorders of
the
-globin genes. However, more studies are needed to ascertain whether the ability to overcome all position effects (which may not be
possible) is required or whether strong enhancers providing robust
expression at a subset of integration sites will suffice.
The technique of RMCE overcomes limitations due to differences in
position effects and copy number, but it also restricts the number of
loci examined. We have measured expression at three loci that differ
markedly in permissivity for expression; a cassette containing the
HBB promoter but not the LCR is not expressed at a
detectable level at RL6, whereas this cassette is readily expressed at
RL5 and RL4 (orientation B). Expression is enhanced by appropriate DNA
fragments from the LCR at all three loci, and in all cases, flow
cytometry showed that all of the cells in the population contained
EGFP. Thus, enhancement occurring by an increase in the fraction of
cells expressing the reporter gene (46) was not observed
in the current experiments. Further studies are required to determine
whether the enhancement seen here results exclusively from an increased
rate of expression, an increase in the fraction of time that a cell is
expressing (13), or some combination of effects
(4). EGFP is a stable protein, and cells that have ceased
expression of the EGFP gene will continue to show EGFP fluorescence for some time, thus making it difficult to see transiently nonexpressing cells. Although we have studied three loci with strikingly different expression properties, it is possible that other
sites are subject to stronger negative regulation and our current
studies would not reveal regulatory functions needed to overcome these
stronger negative effects. For instance, clones containing each of the
expression cassettes at RL5 were monitored for 6 months but no evidence
of silencing was observed (data not shown). Thus, the ability of
enhancers to prevent silencing cannot be assayed at the RL5 locus.
Two types of orientation effect were observed in these studies.
Cassettes at RL4 are expressed in only one orientation, and cassettes
at RL6 are less responsive to enhancers in one orientation. Recent
studies (14) show that silencing correlated with
methylation of regulatory elements in the cassette but not with changes
in chromatin structure (DNase-hypersensitive sites still formed at HS2
and HS3). Presumably, some sequences flanking the RL4 and RL6
integration sites influence methylation and expression. Two possibilities include effects of the direction of replication and
interfering transcription from an adjacent gene. Studies of the
sequences flanking the integration sites should be informative.
In contrast to previous results (26), we see no difference
between the enhancement by individual HS cores and individual HS units
for the HBB-EGFP hybrid reporter gene at these loci in MEL
cells. Several possibilities could explain the difference. For
instance, the collection of random integration sites sampled in the
earlier studies with K562 cells may have been less permissive for
expression than the sites in MEL cells examined in this study and,
hence, were more dependent on the functions provided by the sequences
flanking individual HS cores. Also, the HBE-luciferase reporter used in previous studies may be more sensitive to the effects
of the sequences flanking the cores. Alternatively, it is possible that
the set of clones examined previously for HS cores happened to be
subject to more negative position effects than the set of clones
examined for HS units and, hence, the result could reflect the
limitations of the assay available at that time. Comparison of
cassettes containing HS units and cores at even less permissive loci by
RMCE may provide a better evaluation of whether individual units have
stronger activity than single cores. Indeed, some of the data obtained
by RMCE are suggestive of a role of the sequences flanking the cores
even for single HSs. For example, treatment of clones containing the
HS3_unit cassette with HMBA produced a stronger induction than did
treatment of clones containing the HS3_core cassette, at both RL4 and
RL5. Thus, the sequences flanking the cores do play a role in LCR
function. Multiple lines of evidence now support the conclusion that
they are needed for synergistic interactions between the HS cores, and
in some (but not all) assays, they are needed for optimal function of a
single HS.
 |
ACKNOWLEDGMENTS |
Plasmids containing mLAR, a fragment spanning the region
including HS5 through HS2, and the linked cores of HS2, HS3, and HS4
were generously provided by Mark Groudine, Tim Townes, and Michel
Sadelain, respectively.
This work was supported by NIH grants DK27635 (to R.H.),
LM05110/HG02238 (to W.M.), and HL38655 and HL554350 (to E.B.). J.M. is
supported partly by the South Africa National Research Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: 206 Althouse
Lab, The Pennsylvania State University, University Park, PA 16802. Phone: (814) 863-0113. Fax: (814) 863-7024. E-mail:
rch8{at}psu.edu.
 |
REFERENCES |
| 1.
|
Alami, R.,
J. M. Greally,
K. Tanimoto,
S. Hwang,
Y. Q. Feng,
J. D. Engel,
S. Fiering, and E. E. Bouhassira.
2000.
Beta-globin YAC transgenes exhibit uniform expression levels but position effect variegation in mice.
Hum. Mol. Genet.
9:631-636[Abstract/Free Full Text].
|
| 2.
|
Bender, M.,
A. Reik,
J. Close,
A. Telling,
E. Epner,
S. Fiering,
R. Hardison, and M. Groudine.
1998.
Description and targeted deletion of 5' HS5 and 6 of the mouse -globin locus control region.
Blood
92:4394-4403[Abstract/Free Full Text].
|
| 3.
|
Bender, M. A.,
M. Bulger,
J. Close, and M. Groudine.
2000.
-globin gene switching and DNase I sensitivity of the endogenous -globin locus in mice do not require the locus control region.
Mol. Cell
5:387-393[CrossRef][Medline].
|
| 4.
|
Bouhassira, E.,
K. Westerman, and P. Leboulch.
1997.
Transcriptional behavior of LCR enhancer elements integrated at the same chromosomal locus by recombinase-mediated cassette exchange.
Blood
90:3332-3344[Abstract/Free Full Text].
|
| 5.
|
Bresnick, E., and L. Tze.
1997.
Synergism between hypersensitive sites confers long-range gene activation by the -globin locus control region.
Proc. Natl. Acad. Sci., USA
94:4566-4571[Abstract/Free Full Text].
|
| 6.
|
Bulger, M., and M. Groudine.
1999.
Looping versus linking: toward a model for long-distance gene activation.
Genes Dev.
13:2465-2477[Free Full Text].
|
| 7.
|
Bulger, M.,
J. H. von Doorninck,
N. Saitoh,
A. Telling,
C. Farrell,
M. A. Bender,
G. Felsenfeld,
R. Axel, and M. Groudine.
1999.
Conservation of sequence and structure flanking the mouse and human beta-globin loci: the beta-globin genes are embedded within an array of odorant receptor genes.
Proc. Natl. Acad. Sci. USA
96:5129-5134[Abstract/Free Full Text].
|
| 8.
|
Bungert, J.,
U. Dave,
K.-C. Lim,
K. H. Kieuw,
J. A. Shavit,
Q. Liu, and J. D. Engel.
1995.
Synergistic regulation of human -globin gene switching by locus control region elements HS3 and HS4.
Genes Dev.
9:3083-3096[Abstract/Free Full Text].
|
| 9.
|
Bungert, J.,
K. Tanimoto,
S. Patel,
Q. Liu,
M. Fear, and J. D. Engel.
1999.
Hypersensitive site 2 specifies a unique function within the human -globin locus control region to stimulate globin gene transcription.
Mol. Cell. Biol.
19:3062-3072[Abstract/Free Full Text].
|
| 10.
|
Caterina, J. J.,
D. J. Ciavatta,
D. Donze,
R. R. Behringer, and T. M. Townes.
1994.
Multiple elements in human -globin locus control region 5' HS2 are involved in enhancer activity and position-independent transgene expression.
Nucleic Acids Res.
22:1006-1011[Abstract/Free Full Text].
|
| 11.
|
Collis, P.,
M. Antoniou, and F. Grosveld.
1990.
Definition of the minimal requirements within the human -globin gene and the dominant control region for high level expression.
EMBO J.
9:233-240[Medline].
|
| 12.
|
Epner, E.,
A. Reik,
D. Cimbora,
A. Telling,
M. Bender,
S. Fiering,
T. Enver,
D. Martin,
M. Kennedy,
G. Keller, and M. Groudine.
1998.
The -globin LCR is not necessary for an open chromatin structure or transcription of the mouse -globin locus.
Mol. Cell
2:447-455[CrossRef][Medline].
|
| 13.
|
Feng, Y. Q.,
R. Alami, and E. E. Bouhassira.
1999.
Enhancer-dependent transcriptional oscillations in mouse erythroleukemia cells.
Mol. Cell. Biol.
19:4907-4917[Abstract/Free Full Text].
|
| 14.
|
Feng, Y. Q.,
M. Lorincz,
S. Fiering,
J. M. Greally, and E. Bouhassira.
2001.
Position effects are influenced by the orientation of a transgene with respect to flanking chromatin.
Mol. Cell. Biol.
21:298-309[Abstract/Free Full Text].
|
| 15.
|
Feng, Y. Q.,
J. Seibler,
R. Alami,
A. Eisen,
K. A. Westerman,
P. Leboulch,
S. Fiering, and E. E. Bouhassira.
1999.
Site-specific chromosomal integration in mammalian cells: highly efficient CRE recombinase-mediated cassette exchange.
J. Mol. Biol.
292:779-785[CrossRef][Medline].
|
| 16.
|
Fiering, S.,
E. Epner,
K. Robinson,
Y. Zhuang,
A. Telling,
M. Hu,
D. I. K. Martin,
T. Enver,
T. J. Ley, and M. Groudine.
1995.
Targeted deletion of 5'HS2 of the murine -globin LCR reveals that it is not essential for proper regulation of the -globin locus.
Genes Dev.
9:2203-2213[Abstract/Free Full Text].
|
| 17.
|
Forrester, W. C.,
U. Novak,
R. Gelinas, and M. Groudine.
1989.
Molecular analysis of the human -globin locus activation region.
Proc. Natl. Acad. Sci. USA
86:5439-5443[Abstract/Free Full Text].
|
| 18.
|
Forrester, W. C.,
C. Thompson,
J. T. Elder, and M. Groudine.
1986.
A developmentally stable chromatin structure in the human -globin gene cluster.
Proc. Natl. Acad. Sci. USA
83:1359-1363[Abstract/Free Full Text].
|
| 19.
|
Fraser, P., and F. Grosveld.
1998.
Locus control regions, chromatin activation and transcription.
Curr. Opin. Cell Biol.
10:361-365[CrossRef][Medline].
|
| 20.
|
Grosveld, F.,
M. Antoniou,
M. Berry,
E. de Boer,
N. Dillon,
J. Ellis,
P. Fraser,
O. Hanscombe,
J. Hurst,
A. Imam,
M. Lindenbaum,
S. Philipsen,
S. Pruzina,
J. Strouboulis,
S. Raguz-Bolognesi, and D. Talbot.
1993.
The regulation of human globin gene switching.
Philos. Trans. R. Soc. Lond. B Biol. Sci.
339:183-191[Medline].
|
| 21.
|
Grosveld, F.,
G. B. van Assendelft,
D. Greaves, and G. Kollias.
1987.
Position-independent, high-level expression of the human -globin gene in transgenic mice.
Cell
51:975-985[CrossRef][Medline].
|
| 22.
|
Hardison, R.,
J. L. Slightom,
D. L. Gumucio,
M. Goodman,
N. Stojanovic, and W. Miller.
1997.
Locus control regions of mammalian -globin gene clusters: combining phylogenetic analyses and experimental results to gain functional insights.
Gene
205:73-94[CrossRef][Medline].
|
| 23.
|
Hug, B. A.,
R. L. Wesselschmidt,
S. Fiering,
M. A. Bender,
E. Epner,
M. Groudine, and T. J. Ley.
1996.
Analysis of mice containing a targeted deletion of -globin locus control region hypersensitive site 3.
Mol. Cell. Biol.
16:2906-2912[Abstract].
|
| 24.
|
Igarashi, K.,
H. Hoshino,
A. Muto,
N. Suwabe,
S. Nishikawa,
H. Nakauchi, and M. Yamamoto.
1998.
Multivalent DNA binding complex generated by small Maf and Bach1 as a possible biochemical basis for -globin locus control region complex.
J. Biol. Chem.
273:11783-11790[Abstract/Free Full Text].
|
| 25.
|
Jackson, J. D.,
W. Miller, and R. C. Hardison.
1996.
Sequences within and flanking hypersensitive sites 3 and 2 of the -globin locus control region required for synergistic versus additive interaction with the -globin gene promoter.
Nucleic Acids Res.
24:4327-4335[Abstract/Free Full Text].
|
| 26.
|
Jackson, J. D.,
H. Petrykowska,
S. Philipsen,
W. Miller, and R. Hardison.
1996.
Role of DNA sequences outside the cores of DNase hypersensitive sites (HSs) in functions of the -globin locus control region: domain opening and synergism between HS2 and HS3.
J. Biol. Chem.
271:11871-11878[Abstract/Free Full Text].
|
| 27.
|
Kaufman, R. M.,
C. T. Pham, and T. J. Ley.
1999.
Transgenic analysis of a 100-kb human beta-globin cluster-containing DNA fragment propagated as a bacterial artificial chromosome.
Blood
94:3178-3184[Abstract/Free Full Text].
|
| 28.
|
Kulozik, A. E.,
S. Sail,
A. Bellan-Koch,
C. R. Bartram,
E. Kohne, and E. Kleihauer.
1991.
The proximal element of the -globin locus control region is not functionally required in vivo.
J. Clin. Investig.
87:2142-2146.
|
| 29.
|
Liu, D.,
J. C. Chang,
P. Moi,
W. Jiu,
Y. W. Kan, and P. T. Curtin.
1992.
Dissection of the enhancer activity of -globin 5' DNase I-hypersensitive site 2 in transgenic mice.
Proc. Natl. Acad. Sci. USA
89:3899-3903[Abstract/Free Full Text].
|
| 30.
|
May, C.,
S. Rivella,
J. Callegari,
G. Heller,
K. M. Gaensler,
L. Luzzatto, and M. Sadelain.
2000.
Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin.
Nature
406:82-86[CrossRef][Medline].
|
| 31.
|
Milot, E.,
J. Strouboulis,
T. Trimborn,
M. Wijgerde,
E. de Boer,
A. Langeveld,
K. Tan-Un,
W. Vergeer,
N. Yannoutsos,
F. Grosveld, and P. Fraser.
1996.
Heterochromatin effects on the frequency and duration of LCR-mediated gene transcription.
Cell
87:105-114[CrossRef][Medline].
|
| 32.
|
Navas, P. A.,
K. R. Peterson,
Q. Li,
E. Skarpidi,
A. Rohde,
S. E. Shaw,
C. H. Clegg,
H. Asano, and G. Stamatoyannopoulos.
1998.
Developmental specificity of the interaction between the locus control region and embryonic or fetal globin genes in transgenic mice with an HS3 core deletion.
Mol. Cell. Biol.
18:4188-4196[Abstract/Free Full Text].
|
| 33.
|
O'Gorman, S.,
D. T. Fox, and G. M. Wahl.
1991.
Recombinase-mediated gene activation and site-specific integration in mammalian cells.
Science
251:1351-1355[Abstract/Free Full Text].
|
| 34.
|
Peterson, K.,
C. Clegg,
P. Navas,
E. Norton,
T. Kimbrough, and G. Stamatoyannopoulos.
1996.
Effect of deletion of 5'HS3 or 5'HS2 of the human -globin LCR on the developmental regulation of globin gene expression in -YAC transgenic mice.
Proc. Natl. Acad. Sci. USA
93:6605-6609[Abstract/Free Full Text].
|
| 35.
|
Philipsen, S.,
D. Talbot,
P. Fraser, and F. Grosveld.
1990.
The -globin dominant control region: hypersensitive site 2.
EMBO J.
9:2159-2167[Medline].
|
| 36.
|
Porcu, S.,
M. Kitamura,
E. Witkowska,
Z. Zhang,
A. Mutero,
C. Lin,
J. Chang, and K. M. Gaensler.
1997.
The human beta globin locus introduced by YAC transfer exhibits a specific and reproducible pattern of developmental regulation in transgenic mice.
Blood
90:4602-4609[Abstract/Free Full Text].
|
| 37.
|
Reik, A.,
A. Telling,
G. Zitnik,
D. Cimbora,
E. Epner, and M. Groudine.
1998.
The locus control region is necessary for gene expression in the human -globin locus but not the maintenance of an open chromatin structure in erythroid cells.
Mol. Cell. Biol.
18:5992-6000[Abstract/Free Full Text].
|
| 38.
|
Ryan, T. M.,
R. R. Behringer,
N. C. Martin,
T. M. Townes,
R. D. Palmiter, and R. L. Brinster.
1989.
A single erythroid-specific DNase I super-hypersensitive site activates high levels of human -globin gene expression in transgenic mice.
Genes Dev.
3:314-323[Abstract/Free Full Text].
|
| 39.
|
Sadelain, M.,
C. H. Wang,
M. Antoniou,
F. Grosveld, and R. C. Mulligan.
1995.
Generation of a high-titer retroviral vector capable of expressing high levels of the human -globin gene.
Proc. Natl. Acad. Sci. USA
92:6728-6732[Abstract/Free Full Text].
|
| 40.
|
Sauer, B.
1996.
Multiplex Cre/lox recombination permits selective site-specific DNA targeting to both a natural and an engineered site in the yeast genome.
Nucleic Acids Res.
24:4608-4613[Abstract/Free Full Text].
|
| 41.
|
Seibler, J.,
D. Schubeler,
S. Fiering,
M. Groudine, and J. Bode.
1998.
DNA cassette exchange in ES cells mediated by Flp recombinase: an efficient strategy for repeated modification of tagged loci by marker-free constructs.
Biochemistry
37:6229-6234[CrossRef][Medline].
|
| 42.
|
Slightom, J.,
J. Bock,
D. Tagle,
D. Gumucio,
M. Goodman,
N. Stojanovic,
J. Jackson,
W. Miller, and R. Hardison.
1997.
The complete sequences of the galago and rabbit -globin locus control regions: extended sequence and functional conservation outside the cores of DNase hypersensitive sites.
Genomics
39:90-94[CrossRef][Medline].
|
| 43.
|
Talbot, D.,
P. Collis,
M. Antoniou,
M. Vidal,
F. Grosveld, and D. R. Greaves.
1989.
A dominant control region from the human -globin locus conferring integration site-independent gene expression.
Nature
338:352-355[CrossRef][Medline].
|
| 44.
|
Talbot, D.,
S. Philipsen,
P. Fraser, and F. Grosveld.
1990.
Detailed analysis of the site 3 region of the human -globin dominant control region.
EMBO J.
9:2169-2178[Medline].
|
| 45.
|
Tuan, D.,
W. Solomon,
Q. Li, and I. M. London.
1985.
The -like globin gene domain in human erythroid cells.
Proc. Natl. Acad. Sci. USA
82:6384-6388[Abstract/Free Full Text].
|
| 46.
|
Walters, M. C.,
S. Fiering,
J. Eidemiller,
W. Magis,
M. Groudine, and D. I. K. Martin.
1995.
Enhancers increase the probability but not the level of gene expression.
Proc. Natl. Acad. Sci. USA
92:7125-7129[Abstract/Free Full Text].
|
| 47.
|
Wijgerde, M.,
F. Grosveld, and P. Fraser.
1995.
Transcription complex stability and chromatin dynamics in vivo.
Nature
377:209-213[CrossRef][Medline].
|
Molecular and Cellular Biology, May 2001, p. 2969-2980, Vol. 21, No. 9
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.9.2969-2980.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wang, H., Zhang, Y., Cheng, Y., Zhou, Y., King, D. C., Taylor, J., Chiaromonte, F., Kasturi, J., Petrykowska, H., Gibb, B., Dorman, C., Miller, W., Dore, L. C., Welch, J., Weiss, M. J., Hardison, R. C.
(2006). Experimental validation of predicted mammalian erythroid cis-regulatory modules. Genome Res
16: 1480-1492
[Abstract]
[Full Text]
-
Hu, X., Bulger, M., Bender, M. A., Fields, J., Groudine, M., Fiering, S.
(2006). Deletion of the core region of 5' HS2 of the mouse {beta}-globin locus control region reveals a distinct effect in comparison with human {beta}-globin transgenes. Blood
107: 821-826
[Abstract]
[Full Text]
-
King, D. C., Taylor, J., Elnitski, L., Chiaromonte, F., Miller, W., Hardison, R. C.
(2005). Evaluation of regulatory potential and conservation scores for detecting cis-regulatory modules in aligned mammalian genome sequences. Genome Res
15: 1051-1060
[Abstract]
[Full Text]
-
Feng, Y.-Q., Warin, R., Li, T., Olivier, E., Besse, A., Lobell, A., Fu, H., Lin, C. M., Aladjem, M. I., Bouhassira, E. E.
(2005). The Human {beta}-Globin Locus Control Region Can Silence as Well as Activate Gene Expression. Mol. Cell. Biol.
25: 3864-3874
[Abstract]
[Full Text]
-
Martowicz, M. L., Grass, J. A., Boyer, M. E., Guend, H., Bresnick, E. H.
(2005). Dynamic GATA Factor Interplay at a Multicomponent Regulatory Region of the GATA-2 Locus. J. Biol. Chem.
280: 1724-1732
[Abstract]
[Full Text]
-
Vieira, K. F., Levings, P. P., Hill, M. A., Crusselle, V. J., Kang, S.-H. L., Engel, J. D., Bungert, J.
(2004). Recruitment of Transcription Complexes to the {beta}-Globin Gene Locus in Vivo and in Vitro. J. Biol. Chem.
279: 50350-50357
[Abstract]
[Full Text]
-
Kang, S.-H. L., Levings, P. P, Andersen, F., Laipis, P. J, Berns, K. I, Zori, R. T, Bungert, J.
(2004). Locus control region elements HS2 and HS3 in combination with chromatin boundaries confer high-level expression of a human {beta}-globin transgene in a centromeric region. GENES CELLS
9: 1043-1053
[Abstract]
[Full Text]
-
Hanawa, H., Hargrove, P. W., Kepes, S., Srivastava, D. K., Nienhuis, A. W., Persons, D. A.
(2004). Extended {beta}-globin locus control region elements promote consistent therapeutic expression of a {gamma}-globin lentiviral vector in murine {beta}-thalassemia. Blood
104: 2281-2290
[Abstract]
[Full Text]
-
Harrow, F., Amuta, J. U., Hutchinson, S. R., Akwaa, F., Ortiz, B. D.
(2004). Factors Binding a Non-classical Cis-element Prevent Heterochromatin Effects on Locus Control Region Activity. J. Biol. Chem.
279: 17842-17849
[Abstract]
[Full Text]
-
Follows, G. A., Tagoh, H., Lefevre, P., Morgan, G. J., Bonifer, C.
(2003). Differential transcription factor occupancy but evolutionarily conserved chromatin features at the human and mouse M-CSF (CSF-1) receptor loci. Nucleic Acids Res
31: 5805-5816
[Abstract]
[Full Text]
-
Rivella, S., May, C., Chadburn, A., Riviere, I., Sadelain, M.
(2003). A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta -globin gene transfer. Blood
101: 2932-2939
[Abstract]
[Full Text]
-
Persons, D. A., Hargrove, P. W., Allay, E. R., Hanawa, H., Nienhuis, A. W.
(2003). The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma -globin gene is influenced by chromosomal position effects and vector copy number. Blood
101: 2175-2183
[Abstract]
[Full Text]
-
Jackson, D. A., McDowell, J. C., Dean, A.
(2003). {beta}-Globin locus control region HS2 and HS3 interact structurally and functionally. Nucleic Acids Res
31: 1180-1190
[Abstract]
[Full Text]
-
Sutter, N. B., Scalzo, D., Fiering, S., Groudine, M., Martin, D. I. K.
(2003). Chromatin insulation by a transcriptional activator. Proc. Natl. Acad. Sci. USA
100: 1105-1110
[Abstract]
[Full Text]
-
Johnson, K. D., Norton, J. E., Bresnick, E. H.
(2002). Requirements for utilization of CREB binding protein by hypersensitive site two of the {beta}-globin locus control region. Nucleic Acids Res
30: 1522-1530
[Abstract]
[Full Text]
-
Walters, M. C., Nienhuis, A. W., Vichinsky, E.
(2002). Novel Therapeutic Approaches in Sickle Cell Disease. ASH Education Book
2002: 10-34
[Abstract]
[Full Text]
-
Schubeler, D., Groudine, M., Bender, M. A.
(2001). The murine beta -globin locus control region regulates the rate of transcription but not the hyperacetylation of histones at the active genes. Proc. Natl. Acad. Sci. USA
10.1073/pnas.201394698v1
[Abstract]
[Full Text]
-
Schubeler, D., Groudine, M., Bender, M. A.
(2001). The murine beta -globin locus control region regulates the rate of transcription but not the hyperacetylation of histones at the active genes. Proc. Natl. Acad. Sci. USA
98: 11432-11437
[Abstract]
[Full Text]